CD40 Ligand Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281247 No. of Pages: 72 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of CD40 Ligand in global, including the following market information:
Global CD40 Ligand Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global CD40 Ligand Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five CD40 Ligand companies in 2021 (%)
The global CD40 Ligand market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ISF-35 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CD40 Ligand include Biogen, Inc., Bristol-Myers Squibb Company, eTheRNA Immunotherapies NV, ImmuNext, Inc., Juno Therapeutics Inc., MedImmune, LLC, Targovax AS and XL-protein GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CD40 Ligand manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CD40 Ligand Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global CD40 Ligand Market Segment Percentages, by Type, 2021 (%)
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others
Global CD40 Ligand Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global CD40 Ligand Market Segment Percentages, by Application, 2021 (%)
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others
Global CD40 Ligand Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global CD40 Ligand Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CD40 Ligand revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies CD40 Ligand revenues share in global market, 2021 (%)
Key companies CD40 Ligand sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies CD40 Ligand sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH
1 Introduction to Research & Analysis Reports
1.1 CD40 Ligand Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CD40 Ligand Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CD40 Ligand Overall Market Size
2.1 Global CD40 Ligand Market Size: 2021 VS 2028
2.2 Global CD40 Ligand Revenue, Prospects & Forecasts: 2017-2028
2.3 Global CD40 Ligand Sales: 2017-2028
3 Company Landscape
3.1 Top CD40 Ligand Players in Global Market
3.2 Top Global CD40 Ligand Companies Ranked by Revenue
3.3 Global CD40 Ligand Revenue by Companies
3.4 Global CD40 Ligand Sales by Companies
3.5 Global CD40 Ligand Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 CD40 Ligand Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers CD40 Ligand Product Type
3.8 Tier 1, Tier 2 and Tier 3 CD40 Ligand Players in Global Market
3.8.1 List of Global Tier 1 CD40 Ligand Companies
3.8.2 List of Global Tier 2 and Tier 3 CD40 Ligand Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global CD40 Ligand Market Size Markets, 2021 & 2028
4.1.2 ISF-35
4.1.3 LOAd-700
4.1.4 MEDI-4920
4.1.5 MegaCD40L
4.1.6 Others
4.2 By Type - Global CD40 Ligand Revenue & Forecasts
4.2.1 By Type - Global CD40 Ligand Revenue, 2017-2022
4.2.2 By Type - Global CD40 Ligand Revenue, 2023-2028
4.2.3 By Type - Global CD40 Ligand Revenue Market Share, 2017-2028
4.3 By Type - Global CD40 Ligand Sales & Forecasts
4.3.1 By Type - Global CD40 Ligand Sales, 2017-2022
4.3.2 By Type - Global CD40 Ligand Sales, 2023-2028
4.3.3 By Type - Global CD40 Ligand Sales Market Share, 2017-2028
4.4 By Type - Global CD40 Ligand Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global CD40 Ligand Market Size, 2021 & 2028
5.1.2 Hepatitis B
5.1.3 Bladder Cancer
5.1.4 Liver Cancer
5.1.5 Ovarian Cancer
5.1.6 Others
5.2 By Application - Global CD40 Ligand Revenue & Forecasts
5.2.1 By Application - Global CD40 Ligand Revenue, 2017-2022
5.2.2 By Application - Global CD40 Ligand Revenue, 2023-2028
5.2.3 By Application - Global CD40 Ligand Revenue Market Share, 2017-2028
5.3 By Application - Global CD40 Ligand Sales & Forecasts
5.3.1 By Application - Global CD40 Ligand Sales, 2017-2022
5.3.2 By Application - Global CD40 Ligand Sales, 2023-2028
5.3.3 By Application - Global CD40 Ligand Sales Market Share, 2017-2028
5.4 By Application - Global CD40 Ligand Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global CD40 Ligand Market Size, 2021 & 2028
6.2 By Region - Global CD40 Ligand Revenue & Forecasts
6.2.1 By Region - Global CD40 Ligand Revenue, 2017-2022
6.2.2 By Region - Global CD40 Ligand Revenue, 2023-2028
6.2.3 By Region - Global CD40 Ligand Revenue Market Share, 2017-2028
6.3 By Region - Global CD40 Ligand Sales & Forecasts
6.3.1 By Region - Global CD40 Ligand Sales, 2017-2022
6.3.2 By Region - Global CD40 Ligand Sales, 2023-2028
6.3.3 By Region - Global CD40 Ligand Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America CD40 Ligand Revenue, 2017-2028
6.4.2 By Country - North America CD40 Ligand Sales, 2017-2028
6.4.3 US CD40 Ligand Market Size, 2017-2028
6.4.4 Canada CD40 Ligand Market Size, 2017-2028
6.4.5 Mexico CD40 Ligand Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe CD40 Ligand Revenue, 2017-2028
6.5.2 By Country - Europe CD40 Ligand Sales, 2017-2028
6.5.3 Germany CD40 Ligand Market Size, 2017-2028
6.5.4 France CD40 Ligand Market Size, 2017-2028
6.5.5 U.K. CD40 Ligand Market Size, 2017-2028
6.5.6 Italy CD40 Ligand Market Size, 2017-2028
6.5.7 Russia CD40 Ligand Market Size, 2017-2028
6.5.8 Nordic Countries CD40 Ligand Market Size, 2017-2028
6.5.9 Benelux CD40 Ligand Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia CD40 Ligand Revenue, 2017-2028
6.6.2 By Region - Asia CD40 Ligand Sales, 2017-2028
6.6.3 China CD40 Ligand Market Size, 2017-2028
6.6.4 Japan CD40 Ligand Market Size, 2017-2028
6.6.5 South Korea CD40 Ligand Market Size, 2017-2028
6.6.6 Southeast Asia CD40 Ligand Market Size, 2017-2028
6.6.7 India CD40 Ligand Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America CD40 Ligand Revenue, 2017-2028
6.7.2 By Country - South America CD40 Ligand Sales, 2017-2028
6.7.3 Brazil CD40 Ligand Market Size, 2017-2028
6.7.4 Argentina CD40 Ligand Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa CD40 Ligand Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa CD40 Ligand Sales, 2017-2028
6.8.3 Turkey CD40 Ligand Market Size, 2017-2028
6.8.4 Israel CD40 Ligand Market Size, 2017-2028
6.8.5 Saudi Arabia CD40 Ligand Market Size, 2017-2028
6.8.6 UAE CD40 Ligand Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Biogen, Inc.
7.1.1 Biogen, Inc. Corporate Summary
7.1.2 Biogen, Inc. Business Overview
7.1.3 Biogen, Inc. CD40 Ligand Major Product Offerings
7.1.4 Biogen, Inc. CD40 Ligand Sales and Revenue in Global (2017-2022)
7.1.5 Biogen, Inc. Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company CD40 Ligand Major Product Offerings
7.2.4 Bristol-Myers Squibb Company CD40 Ligand Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 eTheRNA Immunotherapies NV
7.3.1 eTheRNA Immunotherapies NV Corporate Summary
7.3.2 eTheRNA Immunotherapies NV Business Overview
7.3.3 eTheRNA Immunotherapies NV CD40 Ligand Major Product Offerings
7.3.4 eTheRNA Immunotherapies NV CD40 Ligand Sales and Revenue in Global (2017-2022)
7.3.5 eTheRNA Immunotherapies NV Key News
7.4 ImmuNext, Inc.
7.4.1 ImmuNext, Inc. Corporate Summary
7.4.2 ImmuNext, Inc. Business Overview
7.4.3 ImmuNext, Inc. CD40 Ligand Major Product Offerings
7.4.4 ImmuNext, Inc. CD40 Ligand Sales and Revenue in Global (2017-2022)
7.4.5 ImmuNext, Inc. Key News
7.5 Juno Therapeutics Inc.
7.5.1 Juno Therapeutics Inc. Corporate Summary
7.5.2 Juno Therapeutics Inc. Business Overview
7.5.3 Juno Therapeutics Inc. CD40 Ligand Major Product Offerings
7.5.4 Juno Therapeutics Inc. CD40 Ligand Sales and Revenue in Global (2017-2022)
7.5.5 Juno Therapeutics Inc. Key News
7.6 MedImmune, LLC
7.6.1 MedImmune, LLC Corporate Summary
7.6.2 MedImmune, LLC Business Overview
7.6.3 MedImmune, LLC CD40 Ligand Major Product Offerings
7.6.4 MedImmune, LLC CD40 Ligand Sales and Revenue in Global (2017-2022)
7.6.5 MedImmune, LLC Key News
7.7 Targovax AS
7.7.1 Targovax AS Corporate Summary
7.7.2 Targovax AS Business Overview
7.7.3 Targovax AS CD40 Ligand Major Product Offerings
7.7.4 Targovax AS CD40 Ligand Sales and Revenue in Global (2017-2022)
7.7.5 Targovax AS Key News
7.8 XL-protein GmbH
7.8.1 XL-protein GmbH Corporate Summary
7.8.2 XL-protein GmbH Business Overview
7.8.3 XL-protein GmbH CD40 Ligand Major Product Offerings
7.8.4 XL-protein GmbH CD40 Ligand Sales and Revenue in Global (2017-2022)
7.8.5 XL-protein GmbH Key News
8 Global CD40 Ligand Production Capacity, Analysis
8.1 Global CD40 Ligand Production Capacity, 2017-2028
8.2 CD40 Ligand Production Capacity of Key Manufacturers in Global Market
8.3 Global CD40 Ligand Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CD40 Ligand Supply Chain Analysis
10.1 CD40 Ligand Industry Value Chain
10.2 CD40 Ligand Upstream Market
10.3 CD40 Ligand Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 CD40 Ligand Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com